The DOI matches its Crossref record; 83 of the 83 references it cites were found in a registry or an index.
Cognitive defects are reversible in inducible mice expressing pro-aggregant full-length human Tau
Open accessAbstract
Neurofibrillary lesions of abnormal Tau are hallmarks of Alzheimer disease and frontotemporal dementias. Our regulatable (Tet-OFF) mouse models of tauopathy express variants of human full-length Tau in the forebrain (CaMKIIα promoter) either with mutation ΔK280 (pro-aggregant) or ΔK280/I277P/I308P (anti-aggregant). Co-expression of luciferase enables in vivo quantification of gene expression by bioluminescence imaging. Pro-aggregant mice develop synapse loss and Tau-pathology including missorting, phosphorylation and early pretangle formation, whereas anti-aggregant mice do not. We correlated hippocampal Tau pathology with learning/memory performance and synaptic plasticity. Pro-aggregant mice at 16 months of gene expression exhibited severe cognitive deficits in Morris water maze and in passive-avoidance paradigms, whereas anti-aggregant mice were comparable to controls. Cognitive impairment of pro-aggregant mice was accompanied by loss of hippocampal LTP in CA1 and CA3 areas and by a reduction of synaptic proteins and dendritic spines, although no neuronal loss was observed. Remarkably, memory and LTP recovered when pro-aggregant Tau was switched-OFF for ~4 months, Tau phosphorylation and missorting were reversed, and synapses recovered. Moreover, soluble and insoluble pro-aggregant hTau40 disappeared, while insoluble mouse Tau was still present. This study links early Tau pathology without neurofibrillary tangles and neuronal death to cognitive decline and synaptic dysfunction. It demonstrates that Tau-induced impairments are reversible after switching-OFF pro-aggregant Tau. Therefore, our mouse model may mimic an early phase of AD when the hippocampus does not yet suffer from irreversible cell death but cognitive deficits are already striking. It offers potential to evaluate drugs with regard to learning and memory performance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Tau-mediated neurodegeneration arises from multiple pathological mechanisms, including loss of normal function [37–42], gain of toxic function [43–46], aggregation [44, 47–49], and mislocalization [50–52].”
From Tau Ablation Rewires Brain Cell Programs in Health and Restores Function in Disease (2026) · cites this paper as [43]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Developments of a water-maze procedure for studying spatial learning in the rat
Morris, R. (1984) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(84)90007-4 · Cited by 7,180
Short-Term Synaptic Plasticity
Zucker, R. S., & Regehr, W. G. (2002) · Annual Review of Physiology · doi:10.1146/annurev.physiol.64.092501.114547 · Cited by 5,068
Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397
Triple-Transgenic Model of Alzheimer’s Disease with Plaques and Tangles
Oddo, S., Caccamo, A., Shepherd, J. D., Murphy, M. P., Golde, T. E., Kayed, R., Metherate, R., Mattson, M. P., Akbari, Y., & LaFerla, F. M. (2003) · Neuron · doi:10.1016/s0896-6273(03)00434-3 · Cited by 4,126
The molecular pathology of Alzheimer's disease
Selkoe, D. J. (1991) · Neuron · doi:10.1016/0896-6273(91)90052-2 · Cited by 2,708
Lee, V. M.-Y., Goedert, M., & Trojanowski, J. Q. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.1121 · Cited by 2,480
Synapse Loss and Microglial Activation Precede Tangles in a P301S Tauopathy Mouse Model
Yoshiyama, Y., Higuchi, M., Zhang, B., Huang, S.-M., Iwata, N., Saido, T. C., Maeda, J., Suhara, T., Trojanowski, J. Q., & Lee, V. M.-Y. (2007) · Neuron · doi:10.1016/j.neuron.2007.01.010 · Cited by 2,208
Tau-mediated neurodegeneration in Alzheimer’s disease and related disorders
Ballatore, C., Lee, V. M.-Y., & Trojanowski, J. Q. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2194 · Cited by 2,174
Tau Suppression in a Neurodegenerative Mouse Model Improves Memory Function
SantaCruz, K., Lewis, J., Spires, T., Paulson, J., Kotilinek, L., Ingelsson, M., Guimaraes, A., DeTure, M., Ramsden, M., McGowan, E., et al. (2005) · Science · doi:10.1126/science.1113694 · Cited by 2,014
Cited by
Sorted by citations
Tau in physiology and pathology
Wang, Y., & Mandelkow, E. (2016) · Nature Reviews Neuroscience · doi:10.1038/nrn.2015.1 · Cited by 2,251
Self-citationTau pathology and neurodegeneration
Spillantini, M. G., & Goedert, M. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70090-5 · Cited by 1,133
The Neuropathology of Chronic Traumatic Encephalopathy
McKee, A. C., Stein, T. D., Kiernan, P. T., & Alvarez, V. E. (2015) · Brain Pathology · doi:10.1111/bpa.12248 · Cited by 585
Neuronal activity regulates extracellular tau in vivo
Yamada, K., Holth, J. K., Liao, F., Stewart, F. R., Mahan, T. E., Jiang, H., Cirrito, J. R., Patel, T. K., Hochgräfe, K., Mandelkow, E., et al. (2014) · The Journal of Experimental Medicine · doi:10.1084/jem.20131685 · Cited by 606
Self-citationTau impairs neural circuits, dominating amyloid-β effects, in Alzheimer models in vivo
Busche, M. A., Wegmann, S., Dujardin, S., Commins, C., Schiantarelli, J., Klickstein, N., Kamath, T. V., Carlson, G. A., Nelken, I., & Hyman, B. T. (2019) · Nature Neuroscience · doi:10.1038/s41593-018-0289-8 · Cited by 413
The complexity of tau in Alzheimer’s disease
Naseri, N. N., Wang, H., Guo, J. D., Sharma, M., & Luo, W. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.04.022 · Cited by 390
Role of Amyloid-β and Tau Proteins in Alzheimer’s Disease: Confuting the Amyloid Cascade
Gulisano, W., Maugeri, D., Baltrons, M. A., Fà, M., Amato, A., Palmeri, A., D’Adamio, L., Grassi, C., Devanand, D. P., Honig, L. S., et al. (2018) · Journal of Alzheimer's Disease · doi:10.3233/jad-179935 · Cited by 313
Zempel, H., Luedtke, J., Kumar, Y., Biernat, J., Dawson, H., Mandelkow, E., & Mandelkow, E. (2013) · The EMBO Journal · doi:10.1038/emboj.2013.207 · Cited by 283
Self-citationTracy, T. E., Sohn, P. D., Minami, S. S., Wang, C., Min, S.-W., Li, Y., Zhou, Y., Le, D., Lo, I., Ponnusamy, R., et al. (2016) · Neuron · doi:10.1016/j.neuron.2016.03.005 · Cited by 277
Lost after translation: missorting of Tau protein and consequences for Alzheimer disease
Zempel, H., & Mandelkow�, E. (2014) · Trends in Neurosciences · doi:10.1016/j.tins.2014.08.004 · Cited by 284
Self-citationCellular and pathological functions of tau
Bravo, C. P., Naguib, S. A., & Gan, L. (2024) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-024-00753-9 · Cited by 255
Iba, M., McBride, J. D., Guo, J. L., Zhang, B., Trojanowski, J. Q., & Lee, V. M.-Y. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1458-4 · Cited by 223
Lashley, T., Rohrer, J. D., Mead, S., & Révész, T. (2015) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12250 · Cited by 233
Are tau aggregates toxic or protective in tauopathies?
Cowan, C. M., & Mudher, A. (2013) · Frontiers in Neurology · doi:10.3389/fneur.2013.00114 · Cited by 215
A role for tau at the synapse in Alzheimer’s disease pathogenesis
Pooler, A. M., Noble, W., & Hanger, D. P. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.09.018 · Cited by 203
Toward more predictive genetic mouse models of Alzheimer’s disease
Onos, K. D., Sukoff Rizzo, S. J., Howell, G. R., & Sasner, M. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2015.12.003 · Cited by 156
The Chemokine MIP-1α/CCL3 impairs mouse hippocampal synaptic transmission, plasticity and memory
Marciniak, E., Faivre, E., Dutar, P., Alves Pires, C., Demeyer, D., Caillierez, R., Laloux, C., Buée, L., Blum, D., & Humez, S. (2015) · Scientific Reports · doi:10.1038/srep15862 · Cited by 148
Tau-mediated synaptic and neuronal dysfunction in neurodegenerative disease
Tracy, T. E., & Gan, L. (2018) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2018.04.027 · Cited by 155
Stancu, I.-C., Vasconcelos, B., Ris, L., Wang, P., Villers, A., Peeraer, E., Buist, A., Terwel, D., Baatsen, P., Oyelami, T., et al. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1413-4 · Cited by 143
Zempel, H., Dennissen, F. J. A., Kumar, Y., Luedtke, J., Biernat, J., Mandelkow, E., & Mandelkow�, E. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.784702 · Cited by 147
Self-citationRemoving endogenous tau does not prevent tau propagation yet reduces its neurotoxicity
Wegmann, S., Maury, E. A., Kirk, M. J., Saqran, L., Roe, A., DeVos, S. L., Nicholls, S., Fan, Z., Takeda, S., Cagsal‐Getkin, O., et al. (2015) · The EMBO Journal · doi:10.15252/embj.201592748 · Cited by 132
Hochgräfe, K., Sydow, A., Matenia, D., Cadinu, D., Könen, S., Petrova, O. M., Pickhardt, M., Goll, P., Morellini, F., Mandelkow�, E., et al. (2015) · Acta Neuropathologica Communications · doi:10.1186/s40478-015-0204-4 · Cited by 140
Self-citationTherapeutic strategies for tau mediated neurodegeneration
Yoshiyama, Y., Lee, V. M. ‐., & Trojanowski, J. Q. (2012) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-303144 · Cited by 137
Levenga, J., Krishnamurthy, P., Rajamohamedsait, H. B., Wong, H., Franke, T. F., Cain, P., Sigurdsson, E. M., & Hoeffer, C. A. (2013) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-1-34 · Cited by 131
Expression of A152T human tau causes age‐dependent neuronal dysfunction and loss in transgenic mice
Maeda, S., Djukic, B., Taneja, P., Yu, G.-Q., Lo, I., Davis, A., Craft, R., Guo, W., Wang, X., Kim, D., et al. (2016) · EMBO Reports · doi:10.15252/embr.201541438 · Cited by 133
Transgenic Mouse Models of Alzheimer’s Disease: An Integrative Analysis
Sanchez-Varo, R. M., Mejias‐Ortega, M., Fernandez-Valenzuela, J. J., Nuñez‐Diaz, C., Cáceres-Palomo, L., Vegas‐Gomez, L., Sánchez‐Mejías, E., Trujillo‐Estrada, L., García‐León, J. A., Moreno‐González, I., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105404 · Cited by 134
Barbero-Camps, E., Fernández, A., Martínez, L., Fernández-Checa, J. C., & Colell, A. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt201 · Cited by 114
Decker, J. M., Krüger, L., Sydow, A., Dennissen, F. J. A., Šišková, Z., Mandelkow�, E., & Mandelkow, E. (2016) · EMBO Reports · doi:10.15252/embr.201541439 · Cited by 130
Self-citationMicroglia in Alzheimer’s Disease in the Context of Tau Pathology
Perea, J. R., Bolós, M., & Ávila, J. (2020) · Biomolecules · doi:10.3390/biom10101439 · Cited by 134
New perspectives on the role of tau in Alzheimer's disease. Implications for therapy
Medina, M., & Ávila, J. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.01.013 · Cited by 123
Wang, P., Joberty, G., Buist, A., Vanoosthuyse, A., Stancu, I., Vasconcelos, B., Pierrot, N., Faelth-Savitski, M., Kienlen‐Campard, P., Octave, J., et al. (2017) · Acta Neuropathologica · doi:10.1007/s00401-016-1663-9 · Cited by 120
Synaptic tau: A pathological or physiological phenomenon?
Robbins, M., Clayton, E. L., & Schierle, G. S. K. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01246-y · Cited by 127
The Role of Protein Misfolding and Tau Oligomers (TauOs) in Alzheimer′s Disease (AD)
Mroczko, B., Groblewska, M., & Litman‐Zawadzka, A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20194661 · Cited by 111
Kaniyappan, S., Chandupatla, R., Mandelkow, E., & Mandelkow, E. (2017) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2017.04.002 · Cited by 100
Self-citationTau-mediated synaptic damage in Alzheimer’s disease
Jadhav, S., Cubinkova, V., Zimova, I., Brezováková, V., Maďari, A., Cigánková, V., & Žilka, N. (2015) · Translational Neuroscience · doi:10.1515/tnsci-2015-0023 · Cited by 97
Acetylation mimic of lysine 280 exacerbates human Tau neurotoxicity in vivo
Gorsky, M. K., Burnouf, S., Dols, J., Mandelkow�, E., & Partridge, L. (2016) · Scientific Reports · doi:10.1038/srep22685 · Cited by 93
Self-citationDujardin, S., Colin, M., & Buée, L. (2014) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12200 · Cited by 88
Kumar, S., Tepper, K., Kaniyappan, S., Biernat, J., Wegmann, S., Mandelkow, E., Müller, D. J., & Mandelkow�, E. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.554725 · Cited by 88
Self-citationPro-aggregant Tau impairs mossy fiber plasticity due to structural changes and Ca++ dysregulation
Decker, J. M., Krüger, L., Sydow, A., Zhao, S., Frotscher, M., Mandelkow�, E., & Mandelkow, E. (2015) · Acta Neuropathologica Communications · doi:10.1186/s40478-015-0193-3 · Cited by 86
Self-citationGötz, J., Xia, D., Leinenga, G., Chew, Y. L., & Nicholas, H. (2013) · Frontiers in Neurology · doi:10.3389/fneur.2013.00072 · Cited by 91
Hu, J.-Y., Zhang, D.-L., Liu, X., Li, X.-S., Cheng, X., Chen, J., Du, H., & Liang, Y. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.11.022 · Cited by 81
Héraud, C., Goufak, D., Ando, K., Leroy, K., Suain, V., Yilmaz, Z., De Decker, R., Authelet, M., Laporte, V., Octave, J.-N., et al. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.09.010 · Cited by 80
TDP-43 suppresses tau expression via promoting its mRNA instability
Gu, J., Wu, F., Xu, W., Shi, J., Hu, W. H., Jin, N., Qian, W., Wang, X., Iqbal, K., Gong, C., et al. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx175 · Cited by 80
Wu, X., Piña-Crespo, J., Zhang, Y., Chen, X., & Xu, H. (2017) · Chinese Medical Journal · doi:10.4103/0366-6999.220313 · Cited by 81
Analysis of in vivo turnover of tau in a mouse model of tauopathy
Yamada, K., Patel, T. K., Hochgräfe, K., Mahan, T. E., Jiang, H., Stewart, F. R., Mandelkow, E., & Holtzman, D. M. (2015) · Molecular Neurodegeneration · doi:10.1186/s13024-015-0052-5 · Cited by 76
Self-citationThe NLRP3 inflammasome modulates tau pathology and neurodegeneration in a tauopathy model
Stancu, I. C., Lodder, C., Botella Lucena, P., Vanherle, S., Gutiérrez de Ravé, M., Terwel, D., Bottelbergs, A., & Dewachter, I. (2022) · Glia · doi:10.1002/glia.24160 · Cited by 72
Hochgräfe, K., Sydow, A., & Mandelkow, E. (2013) · FEBS Journal · doi:10.1111/febs.12250 · Cited by 72
Self-citationPhysiological and Pathophysiological Implications of Synaptic Tau
Regan, P. L., Whitcomb, D. J., & Cho, K. (2016) · The Neuroscientist · doi:10.1177/1073858416633439 · Cited by 75
Latif‐Hernandez, A., Shah, D., Ahmed, T., Lo, A. C., Callaerts‐Vegh, Z., der Linden, A. V., Balschun, D., & D’Hooge, R. (2016) · Scientific Reports · doi:10.1038/srep36489 · Cited by 69
Self-citationRole of microtubule-associated protein tau phosphorylation in Alzheimer’s disease
Ma, R.-H., Zhang, Y., Hong, X.-Y., Zhang, J., Wang, J., & Liu, G. (2017) · Journal of Huazhong University of Science and Technology [Medical Sciences] · doi:10.1007/s11596-017-1732-x · Cited by 66
Ferroptosis, Pyroptosis, and Cuproptosis in Alzheimer’s Disease
Wang, Q., Sun, J., Chen, T., Song, S., Hou, Y., Feng, L., Fan, C., & Li, M. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00343 · Cited by 62
What is the pathological significance of tau oligomers?
Cowan, C. M., Quraishe, S., & Mudher, A. K. (2012) · Biochemical Society Transactions · doi:10.1042/bst20120135 · Cited by 62
Tau neurotoxicity and rescue in animal models of human Tauopathies
Krüger, L., & Mandelkow, E. (2015) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2015.09.004 · Cited by 63
Self-citationTau Toxicity in Neurodegeneration
Liang, S., Wang, Z.-T., Tan, L., & Yu, J. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02809-3 · Cited by 61
Behind the curtain of tauopathy: a show of multiple players orchestrating tau toxicity
Huang, Y., Wu, Z., & Zhou, B. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-2042-8 · Cited by 58
Wang, Y., Ren, Q., Gong, W.-G., Wu, D., Tang, X., Li, X.-L., Wu, F., Bai, F., Xu, L., & Zhang, Z. (2016) · Oncotarget · doi:10.18632/oncotarget.7798 · Cited by 60
Self-citationCrescenzi, R. L., DeBrosse, C., Nanga, R. P. R., Byrne, M. D., Krishnamoorthy, G., D’Aquilla, K., Nath, H., Morales, K. H., Iba, M., Hariharan, H., et al. (2016) · Hippocampus · doi:10.1002/hipo.22693 · Cited by 55
Daulatzai, M. A. (2013) · Neurotoxicity Research · doi:10.1007/s12640-013-9407-2 · Cited by 56
Microglial activation as a hallmark of neuroinflammation in Alzheimer’s disease
Ebrahimi, R., Nejad, S. S., Tafti, M. F., Karimi, Z., Sadr, S. R., Hussein, D. R., Talebian, N., & Esmaeilpour, K. (2025) · Metabolic Brain Disease · doi:10.1007/s11011-025-01631-9 · Cited by 58
Liu, P., Smith, B. R., Montonye, M. L., Kemper, L. J., Leinonen-Wright, K., Nelson, K. M., Higgins, L., Guerrero, C. R., Markowski, T. W., Zhao, X., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-60777-x · Cited by 51
Potentiating tangle formation reduces acute toxicity of soluble tau species in the rat
d’Orange, M., Aurégan, G., Cheramy, D., Gaudin, M., Lieger, S., Guillermier, M., Stimmer, L., Joséphine, C., Hérard, A., Gaillard, M., et al. (2017) · Brain · doi:10.1093/brain/awx342 · Cited by 50
der Jeugd, A. V., Parra‐Damas, A., Baeta-Corral, R., Soto-Faguás, C. M., Ahmed, T., LaFerla, F. M., Giménez‐Llort, L., D’Hooge, R., & Saura, C. A. (2018) · Scientific Reports · doi:10.1038/s41598-018-24741-0 · Cited by 50
Self-citationGao, Y., Zhong, T., Wang, L., Zhang, N., Zeng, Y., Hu, J.-Y., Dang, H.-B., Chen, J., & Liang, Y. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.04.034 · Cited by 48
The Role of Amyloid-Beta and Tau in the Early Pathogenesis of Alzheimer’s Disease
Yin, X., Qiu, Y., Zhao, C., Zhou, Z., Bao, J., & Qian, W. (2021) · Medical Science Monitor · doi:10.12659/msm.933084 · Cited by 48
Tauopathy contributes to synaptic and cognitive deficits in a murine model for Alzheimer’s disease
Stancu, I., Ris, L., Vasconcelos, B., Marinangeli, C., Goeminne, L., Laporte, V., Haylani, L. E., Couturier, J., Schakman, O., Gailly, P., et al. (2014) · The FASEB Journal · doi:10.1096/fj.13-246702 · Cited by 48
Ramos‐Rodríguez, J. J., Gil, S. M., Rey-Brea, R., Berrocoso, E., & Garcı́a-Alloza, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079947 · Cited by 47
Polydoro, M., de Calignon, A., Suárez‐Calvet, M., Sanchez, L., Kay, K. R., Nicholls, S. B., Roe, A. D., Pitstick, R., Carlson, G. A., Gómez‐Isla, T., et al. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.0881-13.2013 · Cited by 47
Adenosine A 1 receptor antagonist rolofylline alleviates axonopathy caused by human Tau ΔK280
Dennissen, F. J. A., Anglada‐Huguet, M., Sydow, A., Mandelkow�, E., & Mandelkow, E. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1603119113 · Cited by 45
Self-citationApplication of Marine Natural Products against Alzheimer’s Disease: Past, Present and Future
Hu, D., Jin, Y., Hou, X., Zhu, Y., Chen, D., Tai, J., Chen, Q., Shi, C., Ye, J., Wu, M., et al. (2023) · Marine Drugs · doi:10.3390/md21010043 · Cited by 48
Sydow, A., Hochgräfe, K., Könen, S., Cadinu, D., Matenia, D., Petrova, O. M., Joseph, M., Dennissen, F. J. A., & Mandelkow, E. (2016) · Acta Neuropathologica Communications · doi:10.1186/s40478-016-0281-z · Cited by 42
Self-citationThe Pathophysiology of Tau and Stress Granules in Disease
Cruz, A. L., Verma, M., & Wolozin, B. L. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-32-9358-8_26 · Cited by 40
Making the Brain Glow: In Vivo Bioluminescence Imaging to Study Neurodegeneration
Hochgräfe, K., & Mandelkow, E. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8379-1 · Cited by 41
Self-citationDeep Brain Stimulation for Alzheimer’s Disease: Tackling Circuit Dysfunction
Lam, J., Lee, J., Liu, C. Y., Lozano, A. M., & Lee, D. J. (2020) · Neuromodulation Technology at the Neural Interface · doi:10.1111/ner.13305 · Cited by 42
Boehm, J. (2013) · European Journal of Neuroscience · doi:10.1111/ejn.12251 · Cited by 41
Rescue of impaired late–phase long-term depression in a tau transgenic mouse model
Ahmed, T., Blum, D. L., Burnouf, S., Demeyer, D., Buée‐Scherrer, V., D’Hooge, R., Buée, L., & Balschun, D. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.09.015 · Cited by 45
Self-citationAmro, Z., Yool, A. J., & Collins‐Praino, L. E. (2021) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2021.100242 · Cited by 39
Chronic Traumatic Encephalopathy: Is Latency in Symptom Onset Explained by Tau Propagation?Preprint
Kriegel, J., Papadopoulos, Z., & McKee, A. C. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a024059 · Cited by 37
Papanikolopoulou, K., & Skoulakis, E. M. C. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddu726 · Cited by 33
Giong, H.-K., Subramanian, M., Yu, K., & Lee, J.-S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168465 · Cited by 30
Kopach, O., Esteras, N., Wray, S., Rusakov, D. A., & Abramov, A. Y. (2020) · Journal of Cell Science · doi:10.1242/jcs.241687 · Cited by 29
Meng, X., Zhao, W., Yang, R., Xu, S.-Q., Wang, S.-Y., Li, M.-M., Jiang, Y.-K., Hao, Z., Guan, W., Kuang, H., et al. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.119335 · Cited by 26
Ahmed, T., der Jeugd, A. V., Caillierez, R., Buée, L., Blum, D. L., D’Hooge, R., & Balschun, D. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.570223 · Cited by 24
Self-citationp38 Inhibition Decreases Tau Toxicity in Microglia and Improves Their Phagocytic Function
Perea, J. R., Bolós, M., Cuadros, R., García, E., García‐Escudero, V., Hernández, F., McManus, R. M., Heneka, M. T., & Ávila, J. (2022) · Molecular Neurobiology · doi:10.1007/s12035-021-02715-0 · Cited by 24
Tau-Mediated Dysregulation of Neuroplasticity and Glial Plasticity
Koller, E. J., & Chakrabarty, P. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.00151 · Cited by 23
Severe oligomeric tau toxicity can be reversed without long-term sequelae
Martinisi, A., Flach, M., Sprenger, F., Frank, S., Tolnay, M., & Winkler, D. T. (2020) · Brain · doi:10.1093/brain/awaa445 · Cited by 20
Wang, Z., Xiong, L., Wan, W., Duan, L., Bai, X., & Zu, H. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00032 · Cited by 22
Retromer dysfunction at the nexus of tauopathies
Carosi, J. M., Denton, D., Kumar, S., & Sargeant, T. J. (2021) · Cell Death & Differentiation · doi:10.1038/s41418-020-00727-2 · Cited by 16
Suppressing Tau Aggregation and Toxicity by an Anti-Aggregant Tau Fragment
Pir, G. J., Choudhary, B. C., Kaniyappan, S., Chandupatla, R., Mandelkow�, E., Mandelkow, E., & Wang, Y. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1326-z · Cited by 20
Self-citationMuto, V., Koshmanova, E., Ghaemmaghami, P., Jaspar, M., Meyer, C., Elansary, M., Egroo, M. V., Chylinski, D., Berthomier, C., Brandewinder, M., et al. (2020) · SLEEP · doi:10.1093/sleep/zsaa137 · Cited by 26
Clinical Trials: Past, Current, and Future for Atypical Parkinsonian Syndromes
Boxer, A. L., & Tsai, R. M. (2014) · Seminars in Neurology · doi:10.1055/s-0034-1381739 · Cited by 19
Müller-Thomsen, L., Borgmann, D., Morcinek, K., Schröder, S. L., Dengler, B., Moser, N., Neumaier, F., Schneider, T., Schröder, H., & Huggenberger, S. (2020) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2020.03.007 · Cited by 19
Elevation of casein kinase 1ε associated with TDP‐43 and tau pathologies in Alzheimer's disease
Gu, J., Hu, W. H., Tan, X., Qu, S., Chu, D., Gong, C., Iqbal, K., & Liu, F. (2019) · Brain Pathology · doi:10.1111/bpa.12775 · Cited by 18
Lemke, N., Melis, V., Lauer, D., Magbagbeolu, M., Neumann, B., Harrington, C. R., Riedel, G., Wischik, C. M., Theuring, F., & Schwab, K. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.014890 · Cited by 15
Akt-activated GSK3β inhibitory peptide effectively blocks tau hyperphosphorylation
Lee, E., Lee, Y., Yang, S., Gong, E. J., Kim, J., Ha, N., Jo, D., Mattson, M. P., & Lee, J. (2024) · Archives of Pharmacal Research · doi:10.1007/s12272-024-01513-1 · Cited by 19
Regulation of Tau Homeostasis and Toxicity by Acetylation
Tracy, T. E., Claiborn, K. C., & Gan, L. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-32-9358-8_4 · Cited by 17
Presynaptic Pathophysiology Encoded in Different Domains of Tau – Hyper-Versus Hypoexcitability?
Decker, J. M., & Mandelkow, E. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-32-9358-8_8 · Cited by 15
Self-citationTelencephalic neurocircuitry and synaptic plasticity in rodent spatial learning and memory
Pooters, T., der Jeugd, A. V., Callaerts‐Vegh, Z., & D’Hooge, R. (2015) · Brain Research · doi:10.1016/j.brainres.2015.01.015 · Cited by 15
Self-citationCritical thinking of Alzheimer’s transgenic mouse model: current research and future perspective
Li, X., Quan, M., Wei, Y., Wang, W., Xu, L., Wang, Q., & Jia, J. (2023) · Science China Life Sciences · doi:10.1007/s11427-022-2357-x · Cited by 14
Vourkou, E., Ruiz, E., Mahajan, S., Mudher, A. K., & Skoulakis, E. M. C. (2023) · Journal of Neuroscience · doi:10.1523/jneurosci.1374-22.2023 · Cited by 11
Spreading of Tau Protein Does Not Depend on Aggregation Propensity
Rodrigues, S., Anglada‐Huguet, M., Hochgräfe, K., Kaniyappan, S., Wegmann, S., & Mandelkow, E. (2023) · Journal of Molecular Neuroscience · doi:10.1007/s12031-023-02143-w · Cited by 12
Self-citation
Metadata
- Authors
- Van der Jeugd, A., Hochgräfe, K., Ahmed, T., Decker, J. M., Sydow, A., Hofmann, A., Wu, D., Messing, L., Balschun, D., D’Hooge, R., & Mandelkow, E.-M.
- Affiliations
- Center of Advanced European Studies and Research (DE)
- KU Leuven (BE)
- Max Planck Society (DE)
- Corresponding author
- Mandelkow, Eva-Maria
- Venue
- Acta Neuropathologica
- Published
- 2012-04-25
- Volume
- 123
- Issue
- 6
- Pages
- 787-805
- ISSN
- 0001-6322 (ISSN-L)
- 1432-0533
- PMC
- PMC4979687
- OpenAlex
- W2030674642
- Cited by
- 135
- References
- 83
- Citations by year
- 2026: 2 · 2025: 11 · 2024: 6 · 2023: 9 · 2022: 7 · 2021: 9 · 2020: 13 · 2019: 6 · 2018: 6 · 2017: 10 · 2016: 12 · 2015: 19 · 2014: 9 · 2013: 13 · 2012: 3
- FWCI
- 9.43
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Acta Neuropathologica (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Max Planck Institute for Plasma Physics (submittedVersion)
- Max Planck Digital Library (submittedVersion)
- Lirias (submittedVersion)
- DZNE Pub (submittedVersion)
- MPG.PuRe (Max Planck Society) (submittedVersion)
- Funders
- Wellcome Trust (089703)
- Medical Research Council (MC_G1000734)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- tauopathy, Alzheimer's disease, frontotemporal dementia, cognitive impairment, hippocampal long-term potentiation, synaptic plasticity, synaptic loss, dendritic spines, tau phosphorylation, learning and memory, bioluminescence imaging
- MeSH terms
- Alzheimer Disease, Animals, Cognition Disorders, Disease Models, Animal, Hippocampus, Humans, Learning, Mice, Transgenic, Neuropsychological Tests, Synapses, Time Factors, Gene Expression, Neurofibrillary Tangles, tau Proteins, Long-Term Potentiation, Tauopathies, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
